PracticeXpert CEO Interviewed on CEOcast


LOS ANGELES, Jan. 12, 2004 (PRIMEZONE) -- PracticeXpert, Inc. (OTCBB:PXPT), today announced that its chief executive officer, Jonathan Doctor, has been interviewed on CEOcast. The interview is available for listing through to January 16, 2004 at www.ceocast.com.

CEOcast describes itself as "the premier source of original and syndicated streaming broadcast interviews of Chief Executive Officers at public and private news-making companies. Organized by industry, its analysts average over 15 years experience covering and evaluating Wall Street's leading companies.

"CEOcast's programming is distributed to millions of on-line investors at over 700 financial web sites as well as to more than 20,000 portfolio managers, buy-side analysts and traders at more than 3,300 North American institutions. Content is also disseminated to over 7,000 investment research professionals representing over 425 institutions. All content is copyrighted to protect our licensing partners."

About PracticeXpert, Inc.

PracticeXpert, Inc.'s business is conducted through is main operating subsidiary, PracticeXpert Services Corp. PracticeXpert Services Corp, a healthcare technology and services company, is in the business of developing and deploying systems, technologies and services designed to improve operational efficiencies, reduce billing errors and enhance cash flow for medical practitioners. Its services revolve around its flagship Revenue Management System, PXpert(tm), and include medical billing, collections, transcription, clinical trial accruals, contracting and practice management. PracticeXpert bundles its technology applications with its billing and other practice management services to provide a complete and integrated solution to its physician customers. For additional information visit www.practicexpert.com.

Note: Any statements released by PracticeXpert, Inc. that are forward - looking, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Editors and investors are cautioned that forward-looking statements invoke risk and uncertainties that may affect the Company's business prospects and performances. These include economic, competitive, governmental, technological and other factors discussed in the statements and in the Company's filings with the Securities and Exchange Commission.



            

Kontaktdaten